skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Refine Results

Clear All


Show More


Show More

Show More


Show More

Show More

15 Total results for product and free and sample content found

Pink Sheet

US Researchers Working Toward Universal Coronavirus Vaccine

Coronavirus Vaccine

The SARS-CoV-2 outbreak has the federal government working not only on a vaccine candidate specifically targeted at the novel coronavirus but also thinking more broadly about ways to head off future potential pandemics with emerging pathogens.

Pink Sheet

Coronavirus Supply Chain Threats Demand Coordinated Industry Response

Emergency Agency Meeting

Just as they did during the heparin crisis a decade ago, pharmaceutical companies must coordinate on coronavirus, Rx-360 CEO says.

Pink Sheet

Coronavirus Efforts Could Benefit From Little-Used Medical Countermeasures Incentives

Coronavirus Efforts Could Benefit From Little-Used Medical Countermeasures Incentives

US FDA’s Medical Countermeasures Initiative authorities like emergency use authorization have not yet had much of an impact on drugs and biologics, but agency is committed to supporting a swift response to the new strain of coronavirus.

Topic Infectious Diseases Vaccines Coronavirus

Pink Sheet

For Coronavirus US FDA Is At The Podium But Not On The Task Force

Hahn speaks at Coronavirus briefing

The FDA is curiously not one of the HHS entities coordinating the US response to the outbreak, but must monitor for manufacturing disruptions and shortages, as well as approve new treatments and diagnostics.

Topic FDA Vaccines Infectious Diseases Coronavirus


Atriva Fast Tracks Antiviral Candidate As Coronavirus Arrives In Germany


The antiviral specialist says MEK inhibitor could work against 2019-nCoV, but tests will take time.

Topic Coronovirus Vaccines


Coronavirus: Can Companies Achieve Vaccine Ambition?


As the death toll rises in China and new cases emerge in other countries, researchers are aiming to slash development times to generate a vaccine against the 2019-nCoV coronavirus.

Topic Coronovirus Research Vaccines


Stockwatch: Earnings Season Catches An Early Cold As Coronavirus Sweeps In


As industry bellwether J&J kicked-off 2019 fourth-quarter and full-year earnings season for life sciences companies, its financial results left investors feeling the cold. But with coronavirus envy sweeping a raft of smaller biotech companies, J&J may have the last laugh.


Moderna Inovio Coronavirus Vaccine Candidates Fast-Tracked By International Coalition


The Coalition for Epidemic Preparedness Innovations adds new deal with mRNA specialist Moderna for rapid development of coronavirus vaccine.

Topic Company Analysis Coronovirus Infectious Diseases Vaccines


Real-World Evidence Sought In Sanofi Pasteur Observational Flu Vaccine Trial

Real-World Evidence Sought In Sanofi Pasteur Observational Flu Vaccine Trial

Vaccine maker Sanofi Pasteur and managed care group Kaiser Permanente have joined forces in an observational trial using electronic medical records from 1.6 million people to highlight the benefits of integrated big data.

Topic Clinical trials Influenza virus Vaccines

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: